Biofarma is a finished-dose manufacturer based in United Arab Emirates. It appears in 90 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), INHRR (VE) and EEC_EAEU. Its GMP standing is certified by ANVISA (Brazil), NAFDAC (NG) and EMA. Customs aggregates show $264K of exports covering 3 molecules to 1 destination in 2025.
| Site | FDA FEI |
|---|---|
| Mereto di Tomba, United Arab Emirates | Not on file |
| Gallarate, United Arab Emirates | Not on file |
| San Pietro Viminario, United Arab Emirates | Not on file |
| Mereto di Tomba, United Arab Emirates | Not on file |
| HORTOLÂNDIA, Brazil | Not on file |
| Brazil, Brazil | 3021095601 |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 39 | None |
| INHRR (VE) | 34 | None |
| EEC_EAEU | 6 | None |
| INFARMED (PT) | 5 | None |
| INVIMA (CO) | 4 | None |
| ARCSA (EC) | 1 | None |
| ANVISA (Brazil) | None | 1 |
| NAFDAC (NG) | None | 1 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $264K | 1 |
| 2024 | Not reported | $920K | 1 |
| 2023 | Not reported | $25K | 1 |
| 2022 | Not reported | $11K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Biofarma comes back tiered against every other supplier able to file there.
Start for free